161 related articles for article (PubMed ID: 40694)
1. Binding characteristics of a major protein in rat ventral prostate cytosol that interacts with estramustine, a nitrogen mustard derivative of 17 beta-estradiol.
Forsgren B; Gustafsson JA; Pousette A; Högberg B
Cancer Res; 1979 Dec; 39(12):5155-64. PubMed ID: 40694
[TBL] [Abstract][Full Text] [Related]
2. The presence in rat and human prostate of proteins that bind steroid-cytostatic complexes.
Forsgren B; Björk P; Carlström K; Gustafsson JA; Pousette A; Högberg B
Prog Clin Biol Res; 1981; 75A():391-407. PubMed ID: 7339627
[TBL] [Abstract][Full Text] [Related]
3. Binding of estramustine, a nitrogen mustard derivative of estradiol-17 beta, in cytosol from rat ventral prostate.
Forsgren B; Högberg B; Gustafsson JA; Pousette A
Acta Pharm Suec; 1978; 15(1):23-32. PubMed ID: 645366
[No Abstract] [Full Text] [Related]
4. [Estracyt (estradiol-nitrogen mustard complex)--estramustine binding protein and its specificity].
Yamanaka H; Imai K; Suzuki T; Yuasa H; Takahashi E
Gan To Kagaku Ryoho; 1984 Oct; 11(10):2106-14. PubMed ID: 6486830
[TBL] [Abstract][Full Text] [Related]
5. Estramustine-binding protein in rat and human prostate.
Forsgren B
Scand J Urol Nephrol Suppl; 1988; 107():56-8. PubMed ID: 3287598
[TBL] [Abstract][Full Text] [Related]
6. Partial characterization and "quantitation" of a human prostatic estramustine-binding protein.
Björk P; Forsgren B; Gustafsson JA; Pousette A; Högberg B
Cancer Res; 1982 May; 42(5):1935-42. PubMed ID: 7066904
[TBL] [Abstract][Full Text] [Related]
7. Studies on the estramustine-binding protein in rat ventral prostate and in human prostate.
Gustafsson JA; Björk P; Carlström K; Forsgren B; Hökfelt T; Pousette A; Högberg B
Scand J Urol Nephrol Suppl; 1980; 55():133-4. PubMed ID: 6163205
[No Abstract] [Full Text] [Related]
8. Mechanism of retention of estramustine in the rat prostate and results of a clinical trial of Estracyt in Japan.
Yamanaka H; Imai K; Yuasa H; Shida K
Prostate; 1981; Suppl 1():95-102. PubMed ID: 7043423
[TBL] [Abstract][Full Text] [Related]
9. Subcellular localization of estramustine in rat ventral prostate following intravenous injection.
Peterson C; Forsgren B; Högberg B
Acta Physiol Scand Suppl; 1983; 515():55-63. PubMed ID: 6578672
[No Abstract] [Full Text] [Related]
10. Influence of sex hormones on prostatic secretion protein, a major protein in rat prostate.
Pousette A; Björk P; Carlström K; Forsgren B; Högberg B; Gustafsson JA
Cancer Res; 1981 Feb; 41(2):688-90. PubMed ID: 7448814
[TBL] [Abstract][Full Text] [Related]
11. Purification and distribution of a major protein in rat prostate that binds estramustine, a nitrogen mustard derivative of estradiol-17 beta.
Forsgren B; Björk P; Carlström K; Gustafsson JA; Pousette A; Högberg B
Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3149-53. PubMed ID: 290993
[TBL] [Abstract][Full Text] [Related]
12. Carcinogen-binding proteins in the rat ventral prostate: specific and nonspecific high-affinity binding sites for benzo(a)pyrene, 3-methylcholanthrene, and 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Söderkvist P; Poellinger L; Gustafsson JA
Cancer Res; 1986 Feb; 46(2):651-7. PubMed ID: 3940634
[TBL] [Abstract][Full Text] [Related]
13. Binding sites for the cytotoxic metabolites of estramustine phosphate (Estracyt) in rat and human pancreas that are distinct from pancreatic estrogen-binding protein.
Björk P; Jönsson U; Andrén-Sandberg A
Pancreas; 1991 Jan; 6(1):77-89. PubMed ID: 1994382
[TBL] [Abstract][Full Text] [Related]
14. The interaction of steroidal alkylating agents with binding components in the soluble fraction of the prostate.
Högberg B; Björk P; Carlström K; Forsgren B; Gustafsson JA; Hökfelt T; Pousette A
Prog Clin Biol Res; 1979; 33():181-99. PubMed ID: 531044
[No Abstract] [Full Text] [Related]
15. Specific binding of estramustine to prostatic proteins.
Forsgren B; Björk P
Urology; 1984 Jun; 23(6 Suppl):34-8. PubMed ID: 6375077
[No Abstract] [Full Text] [Related]
16. Autoradiographic studies of 3H-estramustine in the rat ventral prostate.
Appelgren LE; Forsgren B; Gustafsson JA; Pousette A; Högberg B
Acta Pharmacol Toxicol (Copenh); 1978 Nov; 43(5):368-74. PubMed ID: 726901
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
Yamanaka H; Shida K
Gan To Kagaku Ryoho; 1984 Mar; 11(3):537-44. PubMed ID: 6422861
[TBL] [Abstract][Full Text] [Related]
18. Incorporation of 3H-thymidine and 14C-amino acids into the ventral prostate after in vivo treatment with estradiol-3N-BIS(2-chloroethyl)carbamate-17 beta-phosphate (Estracyt) and its estrogen and cytostatic parts.
Hoisaeter PA
Invest Urol; 1976 Sep; 14(2):85-92. PubMed ID: 972011
[TBL] [Abstract][Full Text] [Related]
19. Metabolic aspects and actions unique to Estracyt.
Sandberg AA
Semin Oncol; 1983 Sep; 10(3 Suppl 3):3-15. PubMed ID: 6364364
[No Abstract] [Full Text] [Related]
20. Characterization of androgen receptor and estramustine binding protein of rat ventral prostatic tissue in organ culture.
Høisaeter PA; Kadohama N; Corrales JJ; Karr JP; Murphy GP; Sandberg AA
J Steroid Biochem; 1981 Mar; 14(3):251-60. PubMed ID: 7218791
[No Abstract] [Full Text] [Related]
[Next] [New Search]
